Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

EuroIntervention 2015;10:1284-1287 published online ahead of print January 2015. DOI: 10.4244/EIJY15M01_04

Thomas Pilgrim
Thomas Pilgrim1, MD; Lorenz Räber1, MD; Andreas Limacher2, PhD; Peter Wenaweser1, MD; Stéphane Cook3, MD; Jean-Christophe Stauffer3, MD; Ali Garachemani4, MD; Aris Moschovitis1, MD; Bernhard Meier1, MD; Peter Jüni2,5, MD; Stephan Windecker1,2*, MD
1. Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland; 2. Clinical Trials Unit Bern, Department of Clinical Research, University of Bern, Bern, Switzerland; 3. Cardiology, University of Fribourg, Fribourg, S

Aims: Stents with a passive coating of titanium-nitride-oxide (TiNO) have been compared with Endeavor® zotarolimus-eluting stents (E

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary artery diseasepercutaneous coronary interventiontitan stentzotarolimus-eluting stent
Read next article
Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

Latest news